Hartford Financial Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.1K | Hold |
4
| – | – | ﹤0.01% | 323 |
|
|
2025
Q1 | $2.54K | Hold |
4
| – | – | ﹤0.01% | 325 |
|
|
2024
Q4 | $2.85K | Hold |
4
| – | – | ﹤0.01% | 340 |
|
|
2024
Q3 | $4.21K | Hold |
4
| – | – | ﹤0.01% | 330 |
|
|
2024
Q2 | $4.21K | Hold |
4
| – | – | ﹤0.01% | 333 |
|
|
2024
Q1 | $3.85K | Hold |
4
| – | – | ﹤0.01% | 340 |
|
|
2023
Q4 | $3.51K | Hold |
4
| – | – | ﹤0.01% | 348 |
|
|
2023
Q3 | $3.29K | Buy |
4
+1
| +33% | +$823 | ﹤0.01% | 347 |
|
|
2023
Q2 | $2.16K | Hold |
3
| – | – | ﹤0.01% | 347 |
|
|
2023
Q1 | $2.47K | Buy |
+3
| New | +$2.47K | ﹤0.01% | 340 |
|
|
2022
Q3 | – | Sell |
-10
| Closed | -$6K | – | 387 |
|
|
2022
Q2 | $6K | Hold |
10
| – | – | ﹤0.01% | 309 |
|
|
2022
Q1 | $7K | Hold |
10
| – | – | ﹤0.01% | 311 |
|
|
2021
Q4 | $6K | Hold |
10
| – | – | ﹤0.01% | 313 |
|
|
2021
Q3 | $6K | Hold |
10
| – | – | ﹤0.01% | 316 |
|
|
2021
Q2 | $6K | Hold |
10
| – | – | ﹤0.01% | 323 |
|
|
2021
Q1 | $5K | Hold |
10
| – | – | ﹤0.01% | 340 |
|
|
2020
Q4 | $5K | Buy |
+10
| New | +$5K | ﹤0.01% | 314 |
|
|
2019
Q1 | – | Sell |
-20
| Closed | -$7K | – | 383 |
|
|
2018
Q4 | $7K | Hold |
20
| – | – | ﹤0.01% | 325 |
|
|
2018
Q3 | $8K | Sell |
20
-130
| -87% | -$52K | ﹤0.01% | 332 |
|
|
2018
Q2 | $52K | Hold |
150
| – | – | 0.02% | 224 |
|
|
2018
Q1 | $51K | Hold |
150
| – | – | 0.03% | 176 |
|
|
2017
Q4 | $56K | Hold |
150
| – | – | 0.03% | 178 |
|
|
2017
Q3 | $67K | Hold |
150
| – | – | 0.03% | 179 |
|
|
2017
Q2 | $73K | Hold |
150
| – | – | 0.03% | 177 |
|
|
2017
Q1 | $58K | Buy |
+150
| New | +$58K | 0.04% | 177 |
|